Telos Corporation Announces First Quarter Results Above Guidance: Reports $29.6 Million of Revenue, 37.0% GAAP Gross Margin, and 42.2% Cash Gross Margin
May 10, 2024 08:02 ET
|
Telos Corporation
Reports First Quarter Results Above High End of Guidance Range on Key Financial MetricsDelivered $29.6 Million of Revenue, Reflecting Outperformance by Security SolutionsGenerated 37.0% GAAP Gross...
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
May 10, 2024 08:00 ET
|
Ocuphire Pharma
FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing small molecule therapies...
Creative Realities Reports Fiscal 2024 First Quarter Results
May 10, 2024 08:00 ET
|
Creative Realities
Creative Realities Reports Fiscal 2024 First Quarter Results; Strong Revenue Growth, Refinancing Underway, 2024 Outlook Reaffirmed
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024 08:00 ET
|
Prime Medicine, Inc.
-- Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial data from planned Phase 1/2 clinical trial expected in 2025 -- --...
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
May 10, 2024 08:00 ET
|
Praxis Precision Medicines, Inc.
BOSTON, May 10, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases
May 10, 2024 08:00 ET
|
Eterna Therapeutics
Eterna Therapeutics to Present at ASGCT on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line
Mobile-health Network Solutions Expands Services to Malaysia
May 10, 2024 08:00 ET
|
Mobile-heath Network Solutions
SINGAPORE, May 10, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced the establishment...
Smart for Life to Attend Vitafoods Europe 2024: Positioned to Identify Strategic Partnerships and Potential Acquisitions
May 10, 2024 08:00 ET
|
Smart for Life, Inc.
MIAMI, May 10, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the...
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
May 10, 2024 08:00 ET
|
Liquidia Corporation
Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data at the American Thoracic Society (ATS) 2024 International Conference.
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky
May 10, 2024 08:00 ET
|
Ekso Bionics Holdings, Inc.
Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif., May 10, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso...